Health FDA Halts Ozempic Ad Over Misleading Claims | Novo Nordisk by Dr Natalie Singh - Health Editor March 4, 2026 by Dr Natalie Singh - Health Editor March 4, 2026 FDA Issues Warning to Novo Nordisk Over Misleading Ozempic Ad The U.S. Food and Drug Administration (FDA) has issued a warning letter to Novo Nordisk, instructing the company to cease … 0 FacebookTwitterPinterestEmail